The company also posted a 37.6 per cent increase in adjusted operating profit, which rose to $46.0 million from $33.4 million ...

Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...

It's that time of the year when the country—from its businesses to economists to the common man—hopes for reforms and tax ...

The government is expected to exceed its fiscal deficit consolidation target for FY25 due to slower-than-budgeted public ...

Shares of Cyient Ltd fell 18.58% after weak Q3 FY25 results and CEO resignation. The DET segment saw a drop in YoY profit, ...

This financial performance was driven by significant greenfield capacity additions of 3.1 GW and consistent plant performance ...

EA has made a pre-announcement regarding the company’s performance for its Q3 FY25 earnings report. The company expected ...

Total expenses of the company rose by around 11.4 percent YoY to Rs 1261.36 crore in Q3FY25 from Rs 1132 crore in Q3FY24, the ...

FY25 revenue grew by 26.2% YoY to $267.4 million, with a 31.2% increase in marketing and sales promotion expenses.

Nuvama slashed its FY25 and 26 EPS estimates by 10.8 per cent and 4.5 per cent, respectively, on lower growth and margins. It suggested a revised target price of Rs 1,660 from Rs 1,700 earlier.

Syngene International slumped 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

SmartSoC Solutions plans to hire 500+ employees, expand globally, and focus on chip design in emerging markets.